Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Menu
Sign in
Sign in

Bayer, BMS, Ono team up to investigate Stivarga, Opdivo combo

Bayer, Bristol-Myers Squibb and Ono Pharmaceutical have entered into a clinical collaboration to evaluate the combination of Stivarga (regorafenib) with Opdivo (nivolumab) in patients with micro-satellite stable metastatic colorectal cancer (MSS mCRC).

Stivarga on its own has previously demonstrated an overall survival benefit versus placebo in the pivotal Phase III CORRECT study, and has shown activity irrespective of micro-satellite status.

Encouraging early data have been seen with the studied combination, such as in a Phase Ib investigator sponsored trial from Japan called REGONIVO, the combination of Opdivo and Stivarge showed promising preliminary efficacy results. The detailed data of the study were presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting.

"The data seen in REGONIVO warrant further exploration of the combination of regorafenib and nivolumab in patients with colorectal cancer. Regorafenib has proven its efficacy and positive safety profile as a third-line monotherapy and we are excited to enter into a clinical collaboration to evaluate this combination with the hope to deliver an additional therapeutic benefit to patients," said Scott Z Fields, senior vice president and head of Oncology Development at Bayer's Pharmaceuticals Division.

Colorectal cancer, also known as bowel cancer, is a cancer that starts in the colon or the rectum. It is one of the most common types of cancer diagnosed in the UK. Most people diagnosed with it are over the age of 60.

19th July 2019

http://www.pharmatimes.com/

0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies